Us Congress 2023-2024 Regular Session

Us Congress House Bill HB7164 Latest Draft

Bill / Introduced Version Filed 02/14/2024

                            I 
118THCONGRESS 
2
DSESSION H. R. 7164 
To advance population research for chronic pain. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY31, 2024 
Ms. C
ARAVEO(for herself and Mr. NUNNof Iowa) introduced the following 
bill; which was referred to the Committee on Energy and Commerce 
A BILL 
To advance population research for chronic pain. 
Be it enacted by the Senate and House of Representa-1
tives of the United States of America in Congress assembled, 2
SECTION 1. SHORT TITLE. 3
This Act may be cited as the ‘‘Advancing Research 4
for Chronic Pain Act of 2024’’. 5
SEC. 2. NATIONAL CHRONIC PAIN INFORMATION SYSTEM. 6
Part P of title III of the Public Health Service Act 7
(42 U.S.C. 280g et seq.) is amended by adding at the end 8
the following: 9
‘‘SEC. 399V–8. CHRONIC PAIN RESEARCH. 10
‘‘(a) I
NGENERAL.—The Secretary, in consultation 11
with the Director of the Centers for Disease Control and 12
VerDate Sep 11 2014 01:18 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H7164.IH H7164
kjohnson on DSK7ZCZBW3PROD with $$_JOB 2 
•HR 7164 IH
Prevention, the Director of the National Institutes of 1
Health, and the heads of other agencies as the Secretary 2
determines appropriate, shall— 3
‘‘(1) utilize available Federal research data to 4
clarify the incidence and prevalence of chronic pain 5
from any source, including injuries, operations, and 6
diseases and conditions; 7
‘‘(2) identify gaps in the available research data 8
and collect deidentified population research data 9
using medical claims and survey data to fill gaps in 10
available research data, such as information con-11
cerning— 12
‘‘(A) incidence and prevalence of specific 13
pain conditions; 14
‘‘(B) demographics and other information, 15
such as age, race, ethnicity, gender, and geo-16
graphic location; 17
‘‘(C) the incidence and prevalence of 18
known chronic pain conditions, as well as of 19
diseases and conditions that include or lead to 20
pain; 21
‘‘(D) risk factors that may be associated 22
with chronic pain conditions, such as genetic 23
and environmental risk factors and other infor-24
mation, as appropriate; 25
VerDate Sep 11 2014 01:18 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H7164.IH H7164
kjohnson on DSK7ZCZBW3PROD with $$_JOB 3 
•HR 7164 IH
‘‘(E) diagnosis and progression markers; 1
‘‘(F) both direct and indirect costs of ill-2
ness; 3
‘‘(G) the epidemiology of the conditions; 4
‘‘(H) the detection, management, and 5
treatment of the conditions; 6
‘‘(I) the epidemiology, detection, manage-7
ment, and treatment of frequent secondary or 8
co-occurring conditions, such as depressive, anx-9
iety, and substance use disorders; 10
‘‘(J) the utilization of medical and social 11
services by patients with chronic pain condi-12
tions, including the direct health care costs of 13
pain treatment, both traditional and alternative, 14
and the indirect costs (such as missed work, 15
public and private disability, and reduction in 16
productivity); and 17
‘‘(K) the effectiveness of evidence-based 18
treatment approaches on chronic pain condi-19
tions; 20
‘‘(3) develop, in collaboration with individuals 21
and organizations with appropriate chronic pain ex-22
pertise, including patients or patient advocates, epi-23
demiologists, representatives of national voluntary 24
health associations, health information technology 25
VerDate Sep 11 2014 01:18 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H7164.IH H7164
kjohnson on DSK7ZCZBW3PROD with $$_JOB 4 
•HR 7164 IH
experts, clinicians, and research scientists, standard 1
definitions and approaches for population research 2
on chronic pain to efficiently promote greater com-3
parability of data; and 4
‘‘(4) disseminate, pursuant to the public 5
webpage under subsection (b), and, as appropriate, 6
to the public and to other Federal departments and 7
agencies, any findings, developed population research 8
standards, and available Federal data sources re-9
lated to chronic pain. 10
‘‘(b) D
ISSEMINATION.—The Secretary, acting 11
through the Director of the Centers for Disease Control 12
and Prevention, shall establish a public webpage, to be 13
known as the Chronic Pain Information Hub, that— 14
‘‘(1) aggregates and summarizes available Fed-15
eral data sources, indicators, and peer-reviewed re-16
search related to chronic pain; 17
‘‘(2) includes an up-to-date summary of com-18
plete, underway, and planned data collection and 19
analysis related to chronic pain that is conducted 20
and supported by the Centers for Disease Control 21
and Prevention; and 22
‘‘(3) translates research findings into clinical 23
tools and resources, recommendations for closing re-24
search gaps, and recommendations for population re-25
VerDate Sep 11 2014 01:18 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H7164.IH H7164
kjohnson on DSK7ZCZBW3PROD with $$_JOB 5 
•HR 7164 IH
search standards for researchers, with recommenda-1
tions updated annually to incorporate research find-2
ings from the prior year. 3
‘‘(c) C
ONFLICTS OFINTEREST.—If an individual or 4
organization that collaborates with the Secretary in car-5
rying out subsection (a) receives a payment or other trans-6
fer of value of a type described in section 7
1128G(a)(1)(A)(vi) of the Social Security Act from a man-8
ufacturer of a drug (including a biological product) or de-9
vice that would be required to be disclosed pursuant to 10
section 1128G(a)(1) of the Social Security Act, if the indi-11
vidual or organization were a covered recipient or if such 12
disclosure were required upon request of or by designation 13
on behalf of a covered recipient pursuant to such section, 14
the individual or organization shall disclose to the Sec-15
retary information regarding such payment or other trans-16
fer of value. The Secretary shall make such disclosures 17
publicly available. 18
‘‘(d) R
EPORT.—Not later than 2 years after the date 19
of the enactment of the Advancing Research for Chronic 20
Pain Act of 2024, the Secretary shall submit a report to 21
Congress concerning the implementation of this section. 22
Such report shall include information on— 23
‘‘(1) the development and maintenance of the 24
Chronic Pain Information Hub; 25
VerDate Sep 11 2014 01:18 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\H7164.IH H7164
kjohnson on DSK7ZCZBW3PROD with $$_JOB 6 
•HR 7164 IH
‘‘(2) the information made available through 1
the Chronic Pain Information Hub; 2
‘‘(3) the data gaps identified, and planned ef-3
forts to address such gaps; 4
‘‘(4) the process established for soliciting feed-5
back from collaborators; and 6
‘‘(5) feedback received from collaborators. 7
‘‘(e) D
EFINITION.—In this section, the term ‘chronic 8
pain’ means persistent or recurrent pain lasting longer 9
than 3 months. 10
‘‘(f) A
UTHORIZATION OF APPROPRIATIONS.—To 11
carry out this section, there is authorized to be appro-12
priated such sums as may be necessary for each of fiscal 13
years 2024 through 2028.’’. 14
Æ 
VerDate Sep 11 2014 01:18 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6301 E:\BILLS\H7164.IH H7164
kjohnson on DSK7ZCZBW3PROD with $$_JOB